Heart surgery kids monitored for blood thinner risks
NCT ID NCT06193863
Summary
This study is collecting real-world safety information about rivaroxaban, a blood-thinning medication, in children who have undergone Fontan heart surgery. Researchers are monitoring 61 pediatric patients to better understand the risks of major and minor bleeding events during treatment. The study observes children already prescribed this medication by their doctors, using existing medical records without requiring extra visits or tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many Locations
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.